SKI Market

Indian Indices

Sensex

82,626.76 -1,048.16
( -1.25%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fynx Capital Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

507962

INE455H01013

8.56025

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

144.04

EPS(TTM)

Face Value()

Div & Yield %

Back

Indo US Bio-Tech standalone net profit declines 20.87% in the September 2025 quarter

Nov 16,2025

Net profit of Indo US Bio-Tech declined 20.87% to Rs 3.45 crore in the quarter ended September 2025 as against Rs 4.36 crore during the previous quarter ended September 2024. Sales rose 39.15% to Rs 30.85 crore in the quarter ended September 2025 as against Rs 22.17 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	30.85	22.17	39
OPM %	13.48	23.14	-
PBDT	3.77	4.63	-19
PBT	3.56	4.45	-20
NP	3.45	4.36	-21

82,626.76 -1,048.16 ( -1.25%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

57,040.53 -599.31 (-1.04%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)